首頁 > 市場調查報告書 > 製藥

以基因為基之藥物開發

市場調查報告書

商品編碼

1392033

個人化基因組學市場：依測試類型、技術、應用、最終用戶、地區

Personalized Genomics Market, By Test Type, By Technology, By Application, By End User, By Geography

出版日期: 2023年10月27日 | 出版商:

Coherent Market Insights | 英文 168 Pages | 商品交期: 2-3個工作天內

價格

簡介目錄

全球個人化基因組學市場規模預計將從 2023 年的 91.4 億美元增加到 2030 年的 277.7 億美元，預測期內複合年成長率為 17.2%。

報告範圍		報告詳情
基準年	2022年	2023年市場規模	91.4億美元
實績資料	2018-2021	預測期	2023-2030
預測期複合年成長率	17.20%	2030年市場規模預測	277.7億美元

圖 1. 個人化基因體學的全球市場佔有率(%)（依地區），2023 年

個人化基因組學是一個快速發展的領域，它將遺傳學、基因組學和個人化醫療結合起來，為個體的基因組成提供有價值的見解。

市場動態：.

全球個人化基因組學市場由多種因素驅動。首先，慢性病的增加和對個體化治療方案的需求正在推動對基因檢測服務的需求。個體化基因組學可以幫助識別患有特定疾病的高風險個體，從而進行早期療育和有針對性的治療。例如，根據 2020 年 9 月發表在《預防慢性病》上的一篇論文，2018 年，一般大眾中 51.8% 的非住院成年人被診斷出至少患有 10 種選定的慢性病中的一種。具體而言，24.6%的成年人患有一種慢性病，27.2%的成年人患有兩種或兩種以上慢性病。

此外，次世代定序和生物資訊學等技術的進步使基因檢測變得更加容易和負擔得起。因此，提供個人化基因組學服務的公司擁有不斷成長的消費群。

但市場也存在一定的抑制因素。人們對隱私和資料安全表示擔憂，因為遺傳資訊高度敏感，如果保護不當，可能會被濫用。監管課題以及對遺傳資料使用和解釋的明確指南的需求也對市場成長構成課題。

儘管存在這些課題，個體化基因組學市場仍存在重大機會。將人工智慧和機器學習演算法與遺傳分析相結合可以提高個體化基因組學服務的準確性和效率。此外，直接面對消費者的基因檢測的擴展以及醫療保健環境中基因檢測的日益採用為該市場的公司提供了充滿希望的成長前景。

本研究的主要特點

本報告對全球個體化基因組市場進行了詳細分析，並列出了以2022年為基準年的預測期（2023-2030）的市場規模和複合年成長率。
該報告還揭示了各個區隔市場的潛在商機，並為該市場說明了一系列有吸引力的投資提案。
該報告還提供了有關市場促進因素、抑制因素、機會、新產品發布和核准、市場趨勢、區域前景、主要企業採取的競爭策略等的重要考察。
該報告根據公司亮點、產品系列、主要亮點、財務實績和策略等參數，介紹了全球個人化基因組市場的主要企業。
該報告的見解使行銷人員和公司負責人能夠就未來的產品發布、升級、市場擴張和行銷策略做出資訊的決策。
本研究報告針對該產業的各個相關人員，如投資者、供應商、產品製造商、經銷商、新進業者和財務分析師。
透過用於分析全球個體化基因組市場的各種策略矩陣，將有助於相關人員做出決策。

介紹
北美洲
美國
加拿大
歐洲
德國
英國
西班牙
法國
義大利
俄羅斯
歐洲其他地區
亞太地區
中國
印度
日本
澳洲
韓國
東南亞國協
其他亞太地區
拉丁美洲
巴西
阿根廷
墨西哥
其他拉丁美洲
中東和非洲
海灣合作理事會國家
以色列
南非
北非
中部非洲
其他中東地區

第10章競爭形勢

23andMe
Mapmygenome
Invitea
Genetic Technology Limited
Lonza
Interleukin Genetics, Inc
GNA Genotek
Helix
MyHeritage
Pathway Genomics
Veritas Genetics
Xcode
Color Genomics
Myriad Genetics
Quest Diagnostics
Bio-Rad Laboratories, Inc.
Illumina
Thermo Fisher Scientific
Qiagen
Genomic Health
Nebula Genomics

第11章章節

調查方法
關於出版商

簡介目錄

Product Code: CMI6210

The global personalized genomics market size is expected to reach US$ 27.77 Billion by 2030, from US$ 9.14 Billion in 2023, at a CAGR of 17.2% during the forecast period.

Report Coverage		Report Details
Base Year:	2022	Market Size in 2023:	US$ 9.14 Bn
Historical Data for:	2018 to 2021	Forecast Period:	2023 - 2030
Forecast Period 2023 to 2030 CAGR:	17.20%	2030 Value Projection:	US$ 27.77 Bn

Figure 1. Global Personalized Genomics Market Share (%), By Region, 2023

Personalized genomics is a rapidly growing field that combines genetics, genomics, and personalized medicine to provide individuals with valuable insights into their genetic makeup.

Market Dynamics:

The global personalized genomics market is driven by several factors. Firstly, the increasing prevalence of chronic diseases and the need for personalized treatment options have created a demand for genetic testing services. Personalized genomics can help identify individuals who are at a higher risk of developing certain diseases, allowing for early intervention and targeted treatment. For instance, in September 2020, according to an article published in Preventing Chronic Disease, in 2018, 51.8% of civilian, noninstitutionalized adults had been diagnosed with at least 1 of 10 selected chronic conditions. More specifically, the 24.6% of adults have 1 chronic condition, and 27.2% have more than two chronic conditions.

Additionally, advancements in technology, such as next-generation sequencing and bioinformatics, have made genetic testing more accessible and affordable. This has led to a growing consumer base for companies offering personalized genomics services.

However, there are also certain restraints in the market. Concerns about privacy and data security have been raised, as genetic information is highly sensitive and can be misused if not properly protected. Regulatory challenges and the need for clear guidelines regarding the use and interpretation of genetic data also pose challenges to market growth.

Despite these challenges, the personalized genomics market presents significant opportunities. The integration of artificial intelligence and machine learning algorithms in genetic analysis can enhance the accuracy and efficiency of personalized genomics services. Additionally, the expansion of direct-to-consumer genetic testing and the increasing adoption of genetic testing in healthcare settings offer promising growth prospects for companies in this market.

Key features of the study:

This report provides in-depth analysis of the global personalized genomics market, and provides market size (US$ Billion) and compound annual growth rate (CAGR%) for the forecast period (2023-2030), considering 2022 as the base year
It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrices for this market
This study also provides key insights about market drivers, restraints, opportunities, new product launches or approval, market trends, regional outlook, and competitive strategies adopted by key players
It profiles key players in the global personalized genomics market based on the following parameters - company highlights, products portfolio, key highlights, financial performance, and strategies
Key companies covered as a part of this study include Personalized Genomics; 23andMe, Mapmygenome, Invitea, Genetic Technology Limited, Lonza, Interleukin Genetics, Inc, GNA Genotek, Helix, MyHeritage, Pathway Genomics, Veritas Genetics, Xcode, Color Genomics, Myriad Genetics, Quest Diagnostics, Bio-Rad Laboratories, Inc., Illumina, Thermo Fisher Scientific, Qiagen, Genomic Health, Nebula Genomics
Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, type up-gradation, market expansion, and marketing tactics
The global personalized genomics market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts
Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the global personalized genomics market

Personalized Genomics Market Detailed Segmentation:

By Test Type
- Oncology Testing
- Infectious Disease Testing
- Neurological Testing
- Cardiovascular Testing
- Others
By Technology
- PCR-based Tests
- Microarray-based Tests
- Sequencing-based Tests
- Others
By Application
- Diagnostics
- Precision Medicine
- Wellness
- Reproductive Health
- Sports Nutrition & Health
- Lifestyle
- Others
By End User
- Hospitals & Clinics
- Research Centers
- Pharmaceutical & Biotechnology Companies
- Diagnostic Laboratories
- Others
By Region
- North America
- Europe
- Asia-Pacific
- Latin America
- Middle East and Africa
Key Players
- 23andMe
- Mapmygenome
- Invitea
- Genetic Technology Limited
- Lonza
- Interleukin Genetics, Inc
- GNA Genotek
- Helix
- MyHeritage
- Pathway Genomics
- Veritas Genetics
- Xcode
- Color Genomics
- Myriad Genetics
- Quest Diagnostics
- Bio-Rad Laboratories, Inc.
- Illumina
- Thermo Fisher Scientific
- Qiagen
- Genomic Health
- Nebula Genomics

1. Research Objectives and Assumptions

Research Objectives
Assumptions
Abbreviations

2. Market Purview

Report Description
- Market Definition and Scope
Executive Summary
- Market Personalized Genomics, By Test Type
- Market Personalized Genomics, By Technology
- Market Personalized Genomics, By Application
- Market Personalized Genomics, By End User
- Market Personalized Genomics, By Region
Coherent Opportunity Map (COM)

3. Market Dynamics, Regulations, and Trends Analysis

Market Dynamics
- Growing demand for personalized medicine and increase in R&D investments
- High costs and complex data interpretation
- Leveraging Big Data and Artificial Intelligence
Impact Analysis
Key Highlights
Regulatory Scenario
Product launch/Approvals
PEST Analysis
PORTER's Analysis
Merger and Acquisition Scenario

4. Global Personalized Genomics Market - Impact of Coronavirus (COVID-19) Pandemic

COVID-19 Epidemiology
Supply Side and Demand Side Analysis
Economic Impact

5. Global Personalized Genomics Market , By Test Type, 2018-2030, (US$ Bn)

Introduction
- Market Share Analysis, 2023 and 2030 (%)
- Y-o-Y Growth Analysis, 2018-2030
- Segment Trends
Oncology Testing
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2018-2030,(US$ Bn)
Infectious Disease Testing
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2018-2030,(US$ Bn)
Neurological Testing
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2018-2030,(US$ Bn)
Cardiovascular Testing
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2018-2030,(US$ Bn)
Others
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2018-2030,(US$ Bn)

6. Global Personalized Genomics Market , By Technology, 2018-2030, (US$ Bn)

Introduction
- Market Share Analysis, 2023 and 2030 (%)
- Y-o-Y Growth Analysis, 2018 - 2030
- Segment Trends
PCR-based Tests
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2018-2030,(US$ Billion)
Microarray-based Tests
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2018-2030,(US$ Billion)
Sequencing-based Tests
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2018-2030,(US$ Billion)
Others
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2018-2030,(US$ Billion)

7. Global Personalized Genomics Market , By Application, 2018-2030, (US$ Bn)

Introduction
- Market Share Analysis, 2023 and 2030 (%)
- Y-o-Y Growth Analysis, 2018 - 2030
- Segment Trends
Diagnostics
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2018-2030,(US$ Billion)
Precision Medicine
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2018-2030,(US$ Billion)
Wellness
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2018-2030,(US$ Billion)
Reproductive Health
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2018-2030,(US$ Billion)
Sports Nutrition & Health
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2018-2030,(US$ Billion)
Lifestyle
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2018-2030,(US$ Billion)
Others
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2018-2030,(US$ Billion)

8. Global Personalized Genomics Market , By End User, 2018-2030, (US$ Bn)

Introduction
- Market Share Analysis, 2023 and 2030 (%)
- Y-o-Y Growth Analysis, 2018 - 2030
- Segment Trends
Hospitals & Clinics
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2018-2030,(US$ Billion)
Research Centers
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2018-2030,(US$ Billion)
Pharmaceutical & Biotechnology Companies
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2018-2030,(US$ Billion)
Diagnostic Laboratories
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2018-2030,(US$ Billion)
Others
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2018-2030,(US$ Billion)

9. Global Personalized Genomics Market , By Region, 2018-2030, (US$ Bn)

Introduction
- Market Share Analysis, By Country, 2023 and 2030 (%)
- Y-o-Y Growth Analysis, For Country 2018 -2030
- Country Trends
North America
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Test Type, 2018-2030,(US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Technology, 2018-2030,(US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Application, 2018-2030,(US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By End User, 2018-2030,(US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2018-2030,(US$ Bn)
U.S.
Canada
Europe
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Test Type, 2018-2030,(US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Technology, 2018-2030,(US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Application, 2018-2030,(US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By End User, 2018-2030,(US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2018-2030,(US$ Bn)
Germany
U.K.
Spain
France
Italy
Russia
Rest of Europe
Asia Pacific
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Test Type, 2018-2030,(US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Technology, 2018-2030,(US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Application, 2018-2030,(US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By End User, 2018-2030,(US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2018-2030,(US$ Bn)
China
India
Japan
Australia
South Korea
ASEAN
Rest of Asia Pacific
Latin America
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Test Type, 2018-2030,(US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Technology, 2018-2030,(US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Application, 2018-2030,(US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By End User, 2018-2030,(US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2018-2030,(US$ Bn)
Brazil
Argentina
Mexico
Rest of Latin America
Middle East & Africa
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Test Type, 2018-2030,(US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Technology, 2018-2030,(US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Application, 2018-2030,(US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By End User, 2018-2030,(US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Country/ Region, 2018-2030,(US$ Bn)
GCC Countries
Israel
South Africa
North Africa
Central Africa
Rest of Middle East

10. Competitive Landscape

23andMe
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
Mapmygenome
Invitea
Genetic Technology Limited
Lonza
Interleukin Genetics, Inc
GNA Genotek
Helix
MyHeritage
Pathway Genomics
Veritas Genetics
Xcode
Color Genomics
Myriad Genetics
Quest Diagnostics
Bio-Rad Laboratories, Inc.
Illumina
Thermo Fisher Scientific
Qiagen
Genomic Health
Nebula Genomics
Analyst Views